Strybol Iben Pharma

Maldegem ·KBO/BCE: BE 0766.610.695

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	22-07-2025	9 d early	2025-00293485
31-12-2023	31-07-2024	30-07-2024	1 d early	2024-00326655
31-12-2022	31-07-2023	07-07-2023	24 d early	2023-00212496

Metric	This company	Sector median	Position in the sector
Solvency	83.5%	20.4%	better than 95% of 1225 sector peers
Net result	€29k	€26k	better than 51% of 1224 sector peers
Equity	€155k	€142k	better than 52% of 1225 sector peers
Gross operating margin	€43k	€217k	better than 19% of 1223 sector peers
Employees (FTE)	0.0	3.6	better than 5% of 886 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€185k
Fixed assets	21/28	€86k
Tangible fixed assets	22/27	€1k
Financial fixed assets	28	€85k
Current assets	29/58	€99k
Amounts receivable within one year	40/41	€11k
Cash & bank	54/58	€87k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€185k
Equity	10/15	€155k
Contributions / capital	10/11	€5k
Reserves	13	€150k
Amounts payable	17/49	€30k
Amounts payable within one year	42/48	€30k
Trade debts payable within one year	44	€141
Income statement
Gross operating margin	9900	€43k
Operating result	9901	€42k
Financial charges	65	€1k
Result before taxes	9903	€40k
Income taxes	67/77	€12k
Net result for the period	9904	€29k
Result to be appropriated	9905	€29k

Summary